Here’s an idea for the fallen unicorn: Animal testing. A debate broke out on Twitter this weekend about whether the blood-testing startup could pivot in the wake of a criminal probe and a federal investigation.

Talking about Theranos with some E. Coast friends in health. Our prediction: A down round and then a pivot to animal testing.